References
- Abutarboush R, Aligbe C, Pappas G, Saha B, Arnaud F, Haque A, Auker C, McCarron R, et al. 2014. Effects of the oxygen-carrying solution OxyVita C on the cerebral microcirculation and systemic blood pressures in healthy rats. J Funct Biomater. 5:246–258.
- Arnaud F, Fasipe D, Philbin N, Rice J, Flournoy WS, Ahlers S, McCarron R, Freilich D. 2007. Hematology patterns after hemoglobin-based oxygen carrier resuscitation from severe controlled hemorrhage with prolonged delayed definitive care. Transfusion. 47:2098–2109.
- Arnaud F, Sieckmann DG, McCarron RM, Moon-Massat PF. 2015. Hemoglobin measurements in samples containing hemoglobin-based oxygen carriers. Clin Chem Lab Med. 53:e219–22. doi: 10.1515/cclm-2015-0197.
- Auker CR, McCarron RM. 2011. US Navy experience with research on, and development of, hemoglobin-based oxygen carriers. J Trauma. 70:S40–S41.
- Belcher JD, Young M, Chen C, Nguyen J, Burhop K, Tran P, Vercellotti GM. 2013. MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice. Blood. 122:2757–2764.
- Cabrales P, Intaglietta M. 2013. Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids. ASAIO J. 59:337–354.
- Drabkin D, Austin J. 1935. Spectrophotometric studies: II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem. 112:51–65.
- Evelyn K, Malloy H. 1938. Micro determination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in a single sample of blood. J Biol Chem. 126:655–662.
- Harrington JP, Wollocko H. 2010. Pre-clinical studies using OxyVita hemoglobin, a zero-linked polymeric hemoglobin: a review. J Artif Org. 13:183–188.
- Harrington JP, Wollocko J, Kostecki E, Wollocko H. 2011. Physicochemical characteristics of OxyVita hemoglobin, a zero-linked polymer: liquid and powder preparations. Artif Cells Blood Subst Immobil Biotechnol. 39:12–18.
- Klaus JA, Kibler KK, Abuchowski A, Koehler RC. 2010. Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion. Artif Cells Blood Subst Immobil Biotechnol. 38:223–229.
- Lippi G, Plebani M, Di Somma S, Cervellin G. 2011. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci. 48:143–153.
- Lippi G, Cervellin G, Favaloro EJ, Plebani M. In vitro and in vivo hemolysis: an unresolved dispute in laboratory medicine. Berlin, Germany: De Gruyter; 2012.
- Moon-Massat P, Mullah SH, Abutarboush R, Saha BK, Pappas G, Haque A, Auker C, McCarron RM, et al. 2015. Cerebral vasoactivity and oxygenation with oxygen carrier M101 in rats. J Neurotrauma. [Epub ahead of print]. doi: 10.1089/neu.2015.3908.
- Nho K, Glower D, Bredehoeft S, Shankar H, Shorr R, Abuchowski A. 1992. PEG-bovine hemoglobin: safety in a canine dehydrated hypovolemic-hemorrhagic shock model. Biomater Artif Cells Immobil Biotechnol. 20:511–524.
- Rentko V, Pearce B, Moon-Massat Maria PF, Gawryl MS. 2006. Hemopure® (HBOC-201, hemoglobin glutamer-250 (bovine)): preclinical studies. In: Robert M, Winslow M, Eds. Blood substitutes. Amsterdam, Boston: Elsevier, pp. 424–436.
- Rousselot M, Delpy E, Drieu La Rochelle C, Lagente V, Pirow R, Rees JF, Hagege A, Le Guen D et al. 2006a. Arenicola marina extracellular hemoglobin: a new promising blood substitute. Biotechnol J. 1:333–345.
- Rousselot M, Jaenicke E, Lamkemeyer T, Harris JR, Pirow R. 2006b. Native and subunit molecular mass and quarternary structure of the hemoglobin from the primitive branchiopod crustacean Triops cancriformis. FEBS J. 273:4055–4071.
- Vandegriff KD, Young MA, Lohman J, Bellelli A, Samaja M, Malavalli A, Winslow RM. 2008. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol. 154:1649–1661.